Partner Content Partner Content Why Does Quant-Led KOL Identification Fail In Growth Markets... When it comes to KOL identification mapping, there is no shortage of quant data around KOL and HCP activity out there.
Partner Content Partner Content Pathway To Effective Stakeholder Mapping Before developing any stakeholder engagement plan, it is crucial to have a clear understanding of all the relevant individuals and groups your product or device could directly impact or interest in
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
